NEWSROOM

Biopharamaceutical

PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision

    Sandusky, OH, Dec. 15, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full-spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutical and nutraceutical treatments based on its own proprietary extraction technology. The RX branded products are PAOG’s first nutraceutical products. The RX branded products have been well received and are now available for sale direct to...

read more

PAOG On Track To Begin Generating Revenue This Year From CBD Nutraceutical Sales

  Sandusky, OH, Sept. 30, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has initiated production on its first line of CBD nutraceuticals and is on track to generate its first revenue this year, in 2021, since entering the CBD market sector. PAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR...

read more

PAOG Confirms Plans For First CBD Nutraceutical Revenue In 2021 Targeting $16 Billion Market

  Sandusky, OH, Sept. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a brief status update on the company’s ongoing initiatives to include confirming plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021. The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027. PAOG plans to...

read more

PAOG CBD RELAX-RX Co-Packing With ALKM And Marketing With USMJ Detailed In Update Scheduled Next Week

Sandusky, OH, March 9, 2021 – -- PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company’s CBD RELAX-RX nutraceutical development plans including intended co-packing with Alkame Holdings, Inc. (OTC Pink: ALKM) and marketing with North American Cannabis Holdings, Inc. (OTC Pink: USMJ). CBD RELAX-RX targets the anxiety and depression treatment market anticipated to reach a value of $18 billion by...

read more

PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook

  Sandusky, OH, January 14, 2021 – -- PAO Group, Inc. (OTC PINK: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year.  The strategic outlook is included in its entirety below: PAOG 2021 Cannabis Biopharmaceutical Strategic Outlook PAOG is a longtime participant in the cannabis sector working on initiatives to introduce cannabis treatments as alternatives to traditional pharmaceuticals, particularly...

read more

PAOG Takes Major CBD Pharmaceutical Development Step Forward

  Sandusky, OH, January 5, 2021 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced a major step forward in the development of a CBD pharmaceutical product. PAOG today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.  PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward initiating an...

read more

PAOG Expects To Report First Post Acquisition Revenue In Q4 2020

Sandusky, OH, December 22, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced that the company expects to realize and report in Q3 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts, Inc. (OTC PINK: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled...

read more

PAOG Building CBD Pharma Capacity In Partnership With PURA – Partnership Includes PAOG Stock Dividend To PURA Shareholders

Sandusky, Ohio – November 12, 2020 - - PAO Group, Inc. (OTC PINK: PAOG) today confirmed a pharmaceutical and neurocritical extraction partnership with Puration, Inc. (OTC PINK: PURA). PURA has acquired a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate in the project to include a pharmaceutical and neurocritical extraction partnership with PAOG. PURA has also established a co-packing partnership with...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »